Protembis, a privately-held emerging cardiovascular medical device company, announced today the establishment of a Scientific ...

In this final PMA module, Instylla has submitted clinical study resultsto the FDA, advancing our pursuit of the indication ...

Cordis Angioguard RX Emboli Capture Guidewire System Filter Distal Indicated for use as a guidewire and EPS to contain and remove embolic material (thrombus/debris) while performing carotid artery ...

NEXTBIOMEDICAL CO., LDT, announced that clinical study results of Nexsphere-F™, a resorbable embolic agent for treating joint pain, have been published in the esteemed Journal of Vascular and ...

Cordis Angioguard RX Emboli Capture Guidewire System Filter Distal Indicated for use as a guidewire and EPS to contain and remove embolic material (thrombus/debris) while performing carotid artery ...

As World Down Syndrome Day approaches on March 21, 2025, the Canadian Down Syndrome Society (CDSS) is launching It Was Never Okay: Forward Not Backward, a national awareness initiative calling on ...

Juice Plus is redefining plant-based wellness with the launch of its all-new Superfood Powder, a groundbreaking drink mix delivering the benefits of 30 different fruits, vegetables and berries, plus ...

2012年，美国FDA拒绝了Osiris的骨髓来源药物Prochymal的上市申请。其宣称的干细胞修复机制与其临床数据脱节，且缺乏可验证的效力测定方法支持。这一结论在Osiris的2012年SEC文件与美国FDA 2017年细胞治疗指南中均有迹可循。这一失败揭示了关键问题：缺乏有效的效力测定、未见明确的作用机制以及未证实MSC在体内发挥"干细胞"的分化能力。

Shape Memory Medical Inc., developer of custom shape memory polymers for endovascular markets, announced that Edward "Ted" Ruppel, President and CEO, is scheduled to speak on Wednesday, March 19th, ...

Q4 2024 Earnings Call Transcript March 12, 2025 InspireMD, Inc. beats earnings expectations. Reported EPS is $-0.18, ...

Question: There is a strong history of blood clots in my family and I was prescribed the progesterone only pill as a result.